These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 185903)

  • 21. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA; Dawes PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
    Waks UA; Maxwell MH; Marks L; Zawada ET; Kaufman JJ
    Circulation; 1978 Jun; 57(6):1165-70. PubMed ID: 639240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
    Williams GH; Hollenberg NK
    N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
    McGrath BP; Ledingham JG; Benedict CR
    Clin Sci Mol Med; 1977 Oct; 53(4):341-8. PubMed ID: 913058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin lowers blood-pressure.
    Gordon DB
    Lancet; 1978 Nov; 2(8097):970-2. PubMed ID: 81992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM; Khosla MC
    Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M; Fiorentini R; Onesti G; Bellini G; Gould AB; Hessan H; Kim KE; Swartz C
    Clin Sci Mol Med; 1978 Jun; 54(6):633-7. PubMed ID: 657733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
    Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI
    Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 36. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
    Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
    Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Converting enzyme, angiotensin II and hypertensive disease.
    Soffer RL; Case DB
    Am J Med; 1978 Jan; 64(1):147-160. PubMed ID: 203191
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.